Advocacy & News

Federal and Regulatory Outreach

AMRPA Statement on Senate Reintroduction of Improving Seniors’ Timely Access to Care Act

Thursday, October 21, 2021

Medicare Advantage Prior Authorization

AMRPA’s Response to US News and World Report’s Rehabilitation Hospital Ranking Methodology for 2022 and 2023

Tuesday, October 12, 2021

US News Reports

AMRPA Response to Second IRF Review Choice Demo Notice

Friday, October 8, 2021

Review Choice Demo

AMRPA Response to CY 2022 Outpatient Prospective Payment System Proposed Rule and Price Transparency Provisions

Friday, September 17, 2021

CMS Price Transparency OPPS

Joint Stakeholder Response to RTI re: Unified Post-Acute Care Technical Expert Panel

Tuesday, September 14, 2021

UPAC CMS post-acute care TEP

AMRPA Comments on 2022 Physician Fee Schedule Proposed Rule

Monday, September 13, 2021

Physician Fee Schedule CMS

AMRPA Policy Statement on Mandatory COVID-19 Vaccination of Health Care ‎Personnel ‎

Thursday, September 9, 2021

AMRPA Response to Requirements Related to Surprise Billing Part 1

Tuesday, September 7, 2021

Surprise Billing CMS

AMRPA Submits Comments re: CY 2022 Home Health Prospective Payment System proposed rule

Thursday, August 26, 2021

Regulatory #COVID19 IRF-PAI

AMRPA Response to CMS/RTI June 2021 TEP on a Unified Post-Acute Care Prospective Payment System

Friday, July 30, 2021

IMPACT Act UPAC

AMRPA Submits Comments to CMS: re FY 2022 IRF PPS Proposed Rule

Friday, June 4, 2021

Regulatory IRF PPS IRF

AMRPA Letter of Support for Prior Authorization Reform Bill H.R. 3173

Friday, May 14, 2021

Medicare Advantage Prior Authorization

PAC Groups Joint Letter of Support for TRIA 2021

Tuesday, April 27, 2021

IMPACT Act IMPACT Act Reset

AMRPA Letter of Support for The Resetting the IMPACT Act (TRIA) of 2021

Thursday, April 15, 2021

IMPACT Act IMPACT Act Reset Post-Acute Care Reform

AMRPA & NALTH Send Joint Response to CMS on Medicare Advantage Prior Authorization Issues during the Public Health Emergency

Thursday, March 18, 2021

Regulatory Medicare Advantage Prior Authorization

AMRPA’s Comment Letter on the CMS Proposed IRF Review Choice Demonstration

Wednesday, February 17, 2021

AMRPA Second Round Comment Letter to NQF on IRF Measure Under Consideration

Tuesday, January 19, 2021

AMRPA Comment Letter to NQF on IRF Measure Under Consideration

Wednesday, January 6, 2021

AMRPA Responds to MedPAC December 2020 Session on IRF Payment Adequacy and Access

Tuesday, December 29, 2020

Regulatory Medicare Advantage #COVID19

AMRPA Submits Comments on HHS RFI on COVID-19 Regulatory Changes

Monday, December 28, 2020

Regulatory Prior Authorization IRF COVID-19

Interested in Becoming a Part of AMRPA?

AMRPA is the nation’s only trade organization dedicated solely to the interests of inpatient rehabilitation and represents more than 650 freestanding rehabilitation hospitals and rehabilitation units of general hospitals. Fill out a membership application today!